What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
As we age, our natural NAD+ levels decline significantly, contributing to fatigue, cognitive fog, metabolic slowdown, and accelerated aging at the cellular level
This blockage can potentially lead to improved metabolic health and reduced fat accumulation
Dietary changes and supplements can still be used to meet everyday vitamin needs, but routine injections can help ensure you stay healthy
A serum B12 test under 200 pg/mL indicates a deficiency
The recommended injection site is the abdomen, in the soft tissue lateral to the navel